Polymer-surfactant nanoparticles for improving oral bioavailability of doxorubicin
- 15 December 2016
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Investigation
- Vol. 47 (1) , 65-73
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetinArchives of Pharmacal Research, 2011
- Effects of myricetin on the bioavailability of doxorubicin for oral drug delivery in Rats: Possible role of CYP3A4 and P-glycoprotein inhibition by myricetinArchives of Pharmacal Research, 2011
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug BindingScience, 2009
- Surfactant–Polymer Nanoparticles Overcome P-Glycoprotein-Mediated Drug EffluxMolecular Pharmaceutics, 2007
- Functional characterization of peptide transporters in MDCKII–MDR1 cell line as a model for oral absorption studiesInternational Journal of Pharmaceutics, 2007
- Surfactant-polymer Nanoparticles: A Novel Platform for Sustained and Enhanced Cellular Delivery of Water-soluble MoleculesPharmaceutical Research, 2007
- The Role of Surfactants in the Reversal of Active Transport Mediated by Multidrug Resistance ProteinsJournal of Pharmaceutical Sciences, 2003
- Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorinEuropean Journal of Cancer, 2002
- A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo BioavailabilityPharmaceutical Research, 1995
- Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological reviewBiochimie, 1984